Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma.

Charlie Alexander Hamm Felix BuschAnna PöhlmannAnnabella ShewaregaYubei HeRobin SchmidtHan XuGero Wieners Bernhard Gebauer Lynn Jeanette Savic

Published in: Journal of hepatocellular carcinoma (2023)

The featured prediction models can be used for the initial non-invasive estimation of HPSF in patients with HCC before TARE to assist in clinical treatment evaluation while potentially sparing ineligible patients from the angiographic shunt evaluation study.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
pulmonary artery
high resolution
peritoneal dialysis
patient reported outcomes
coronary artery
radiofrequency ablation
clinical evaluation